JBIO
Price:
$14.4559
Market Cap:
$471.64M
Jade Biosciences, Inc. is a biotechnology company focused on developing best-in-class therapies to address critical unmet needs in autoimmune diseases. Their lead asset, JADE-001, targets the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for the treatment of immunoglobulin A (IgA) nephropathy. JADE-001 is anticipated to enter clinical trials in the second half of 2025, with initial data expected in the first half of 2026. The company's pipeline also includes two preclinical antibody programs, JADE-002 and JADE-003.
Industry
Biotechnology
IPO Date
2025-04-29
Stock Exchange
NASDAQ
Ticker
JBIO
According to Jade Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 20.33. This represents a change of 13.46% compared to the average of 17.91 of the last 4 quarters.
The mean historical Current Ratio of Jade Biosciences, Inc. over the last ten years is 22.70. The current 20.33 Current Ratio has changed 8.85% with respect to the historical average. Over the past ten years (40 quarters), JBIO's Current Ratio was at its highest in in the March 2025 quarter at 32.01. The Current Ratio was at its lowest in in the June 2024 quarter at 6.51.
Average
22.70
Median
18.61
Minimum
2.64
Maximum
68.37
Discovering the peaks and valleys of Jade Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.49%
Maximum Annual Current Ratio = 68.37
Minimum Annual Increase = -75.28%
Minimum Annual Current Ratio = 2.64
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 20.33 | -2.89% |
| 2024 | 20.93 | 197.13% |
| 2023 | 7.04 | -58.31% |
| 2022 | 16.90 | -75.28% |
| 2021 | 68.37 | 2.49% |
The current Current Ratio of Jade Biosciences, Inc. (JBIO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
16.10
5-year avg
26.71
10-year avg
22.70
Jade Biosciences, Inc.’s Current Ratio is greater than Silence Therapeutics plc (11.74), greater than Lyell Immunopharma, Inc. (5.28), greater than Aldeyra Therapeutics, Inc. (2.58), greater than Kyverna Therapeutics, Inc. (5.16), less than Contineum Therapeutics, Inc. Class A Common Stock (27.50), greater than Genelux Corporation (4.20), greater than XOMA Royalty Corp. (3.91), less than Tectonic Therapeutic, Inc. (26.63), greater than AC Immune S.A. (1.02),
| Company | Current Ratio | Market cap |
|---|---|---|
| 11.74 | $349.53M | |
| 5.28 | $466.30M | |
| 2.58 | $252.47M | |
| 5.16 | $401.13M | |
| 27.50 | $474.88M | |
| 4.20 | $100.44M | |
| 3.91 | $331.00M | |
| 26.63 | $617.75M | |
| 1.02 | $325.94M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jade Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jade Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Jade Biosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Jade Biosciences, Inc. (JBIO)?
What is the highest Current Ratio for Jade Biosciences, Inc. (JBIO)?
What is the 3-year average Current Ratio for Jade Biosciences, Inc. (JBIO)?
What is the 5-year average Current Ratio for Jade Biosciences, Inc. (JBIO)?
How does the current Current Ratio for Jade Biosciences, Inc. (JBIO) compare to its historical average?